evismo

evismo AG is a Swiss digital health startup based in Zurich, founded in February 2018.

The company specializes in a Diagnostics-as-a-Service platform that focuses on remote vital signs monitoring, particularly for cardiovascular diseases. Co-CEOs Willemien Van Den Toorn and Alexander Panos lead the company in its mission to provide earlier and more patient-oriented diagnoses by capturing previously unmeasured health data. The flagship product, CardioFlex®, is a digital long-term ECG analysis service that allows patients to wear a lightweight, waterproof device for up to 30 days. This device continuously monitors cardiac activity, detects abnormalities, and ensures data security, facilitating clearer diagnoses and faster treatment for conditions like cardiac arrhythmias. evismo serves both B2B customers, including general practitioners, specialists, and hospitals, as well as B2C patients who require medically approved diagnostics at home. The company aims to integrate its tools into the workflows of healthcare providers to enhance diagnostic processes and improve patient outcomes.